SPDR S&P Biotech ETF
673 hedge funds and large institutions have $6.63B invested in SPDR S&P Biotech ETF in 2023 Q3 according to their latest regulatory filings, with 63 funds opening new positions, 182 increasing their positions, 245 reducing their positions, and 91 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
673
Holders Change
-33
Holders Change %
-4.67%
% of All Funds
10.73%
Holding in Top 10
17
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-10.53%
% of All Funds
0.27%
New
63
Increased
182
Reduced
245
Closed
91
Calls
$1.32B
Puts
$1.8B
Net Calls
-$485M
Net Calls Change
+$168M
Top Buyers
Top Sellers
| 1 |
1
Bank of America
Charlotte,
North Carolina
|
$596M |
| 2 |
2
Jane Street
New York
|
$69.6M |
| 3 |
3
Twin Tree Management
Dallas,
Texas
|
$2.47M |
| 4 |
HF
4
HRT Financial
New York
|
$0 |
| 5 |
5
Millennium Management
New York
|
$8.71M |
